The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.70
Bid: 18.40
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 0.60 (3.261%)
Open: 18.70
High: 18.70
Low: 18.70
Prev. Close: 18.70
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

11 Jan 2021 07:00

RNS Number : 1568L
Directa Plus PLC
11 January 2021
 

 

11 January 2021

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULATION (596/2014). UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Trading Update

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, is pleased to provide a trading update.

 

Trading

Further to the positive trading update on 3 December 2020, Directa Plus continued to perform strongly in the final weeks of the year, with better-than-expected sales of G+® enhanced face masks and growth at Setcar SA ("Setcar"), the Company's 51%-owned environmental remediation business.

 

As a result, based on its unaudited management accounts, the Company now expects to report total revenue for the year ending 31 December 2020 of approximately €6.5 million, exceeding its previous guidance and current consensus market expectations.

 

Setcar

Throughout 2020, Setcar has continued to build its reputation for service levels and outstanding real-world results, despite the headwinds caused by the Covid-19 pandemic.

Two notable projects that began in 2020 and are ongoing into 2021 include:

· Working with OMV Petrom S.A., the largest energy company in Southern and Eastern Europe, Setcar treated c.2,500 cubic metres of emulsion generated by the up-stream extraction process. This led to the recovery of c.550 metric tonnes of crude oil, with impurities below 1%, which were returned to the refinery for processing. We have been requested to raise to 2000 metres per month the production capacity in 2021.

· Working with Petrotel Lukoil S.A., part of LUKOIL Company, Setcar is completing the draining, cleaning and washing of an oil storage tank, beginning in November 2020. Using Grafysorber® technology, Setcar is recovering hydrocarbons by treating the sludge settled on the tank's bottom. This process will also restore the tank to factory nameplate capacity, optimising ongoing operational use by the customer. The project should be complete by mid-February 2021 and Setcar expects to treat c.3,200 cubic metres of sludge recovering more than 2,000 metric tonnes of hydrocarbons including oil and paraffins that can be sent back to the refinery.

 

Intellectual Property

Directa Plus has now received Notices of Allowance in respect of four patents, ahead of the formal grant, which is expected in the coming months, specifically:

· a US patent for the Company's Graysorber® environmental remediation technology.

· an EU patent for the Company's sustainable, chemical-free G+ production process.

· a US patent for the use of G+® graphene supermodifier to improve the performance of elastomers, specifically tyres; and

· an EU patent covering the same use of G+® supermodifier in tyres.

 

The Company's patent portfolio will be then composed of 42 patents and 25 pending patents, grouped together in some 16 patent families - four covering the Company's unique production process and 12 covering products and applications for G+® graphene.

 

Commenting. for Directa Plus, Giulio Cesareo, Founder and CEO, said:

 

"To have finished 2020 with better revenues than expected even at the start of December is enormously satisfying. We saw a year of hard work, in difficult circumstances, by all of our employees culminate in this success.

 

Our acquisition of Setcar, in partnership with GSP group, continues to prove its value and the business has moved from strength to strength. Through Setcar, we can deploy genuinely world-leading technology and are increasingly able to demonstrate outstanding results with a range of clients in a variety of geographies and projects.

 

Developing our intellectual property portfolio is at the heart of the Company's mission. We believe we have assembled an extensive and highly valuable IP portfolio protecting our chemical-free production process and G+ applications in verticals that have outstanding potential growth.

 

The new partnership started in 2020 with NexTech to develop a new Li-S battery is based on our ability to accurately control the morphology of G+ at scale and is opening a material new vertical for Directa Plus.

 

We look forward to this year with increasing confidence notwithstanding the headwinds from Covid-19."

 

This announcement has been approved by Giulio Cesareo, Chief Executive, on behalf of the Company.

 

ENDS

 

For further information please visit http://www.nextechbatteries.com:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Marco Ferrari, CFO

 

 

 

Cenkos Securities plc (Nominated Adviser and Joint Broker)

+44 131 220 6939

Neil McDonald

Pete Lynch

 

 

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Rick Thompson

Phil Davies

 

 

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson

Edward Lee

 

 

 

 

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products. All our products are hypoallergenic, non-toxic and sustainably produced.

 

About Setcar

Established in 1994, Setcar S.A. has focused since 2000 on providing a complete range of services to solve environmental issues in a safe and efficient way - from chemical analyses for waste identification to the development of tailored solutions for the waste treatment and by developing new technologies for the remediation of contaminated sites. Setcar's offering includes the decontamination of industrial plants and sites, soils contaminated with petroleum products, PCBs or other contaminants and petroleum and other hazardous waste in lagoons. The company offers its services both onshore and offshore.

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBMMRTMTTBBAB
Date   Source Headline
15th Apr 20243:01 pmRNSNotification of major holdings
12th Apr 20247:00 amRNSGiPave® installed at Imola Circuit
25th Mar 20247:00 amRNSEUR 1,000,000 Loan Agreement Signed
22nd Mar 20247:00 amRNSCollaboration with UK-based Heathcoat Fabrics
26th Feb 20247:00 amRNSAcquisition of 49% minority interest in Setcar
31st Jan 20247:00 amRNSContract win with FORD Otosan
20th Dec 20237:00 amRNSAcquisition of groundbreaking technology
15th Dec 202311:44 amRNSExpansion of collaboration with Miguel Caballero
10th Nov 20237:00 amRNSChange of Nominated Adviser
27th Sep 20237:00 amRNSHalf-year Report
18th Sep 20237:00 amRNSStrategic collaboration with The SPECTRUM Group
8th Sep 20237:00 amRNSNotice of Interim Results
7th Sep 20237:00 amRNSSignificant contract secured with LIBERTY Galati
19th Jul 20237:00 amRNSProject tender awarded
29th Jun 20237:00 amRNSDirecta Plus receives two new Italian patents
22nd Jun 20237:00 amRNSNew concept for produced water decontamination
15th Jun 20235:40 pmRNSResult of AGM
8th Jun 20237:00 amRNSNew product launch
19th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
10th May 20237:00 amRNSFinal Results
9th May 20237:00 amRNSNew contract with customer Alfredo Grassi
27th Apr 20237:00 amRNSNotice of Results Presentations
20th Mar 20237:00 amRNSNew Patent Granted
27th Feb 20237:00 amRNSTrading Update and Notice of Results
21st Dec 20227:00 amRNSNew significant contract with Pigmentsolution
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
2nd Dec 20227:00 amRNSTrading Update
29th Nov 20227:00 amRNSGrant Award
21st Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSFirst Commercial Contract in Latin America
21st Oct 20227:00 amRNSFirst Major Commercial Contract for Gipave
17th Oct 20227:00 amRNSBoar Changes
17th Oct 20227:00 amRNSBoard Changes
29th Sep 202211:05 amRNSSecond Price Monitoring Extn
29th Sep 202211:00 amRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSHalf-year Report
1st Sep 20227:00 amRNSTrading Statement
30th Aug 20227:00 amRNSUS Patent Notice
4th Aug 20227:00 amRNSPartnership Extension and US Patent Award
19th Jul 20227:00 amRNSAgreement with REDA Energy for Grafysorber
5th Jul 20227:00 amRNSSupply Agreement
22nd Jun 20227:00 amRNSGrant of Italian Filtration Patent
17th Jun 20223:40 pmRNSResult of AGM
17th Jun 20227:00 amRNSAGM Statement
19th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFinal Results
22nd Apr 20227:00 amRNSPartnership to Develop Automotive Fabrics
4th Apr 20227:00 amRNSUS EPA Authorises Grafysorber for Use in US
7th Mar 20227:00 amRNSOxfordshire Starts Second Trial of GiPave

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.